Loading clinical trials...
Loading clinical trials...
A Pilot Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular Carcinoma
Conditions
Interventions
Atezolizumab
Bevacizumab
+1 more
Locations
1
United States
M D Anderson Cancer Center
Houston, Texas, United States
Start Date
August 8, 2023
Primary Completion Date
November 10, 2023
Completion Date
November 10, 2023
Last Updated
August 26, 2024
NCT06811116
NCT06066138
NCT03937830
NCT07405086
NCT01567930
Lead Sponsor
M.D. Anderson Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions